Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14Esophageal Neoplasms 5Adenocarcinoma Of Esophagus 5Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Sarcoma 3Rectal Neoplasms 3Colorectal Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Osteosarcoma 2Multiple Myeloma 2Kidney Neoplasms 2Head and Neck Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Renal Cell 2Breast Carcinoma In Situ 2Vomiting 1Urologic Neoplasms 1Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Prostate Adenocarcinoma 1Ovarian Neoplasms 1

Interventions

Dexamethasone 17Palonosetron 13Aprepitant 13Ondansetron 12Calcium Dobesilate 12Granisetron 7dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Olanzapine 3Cisplatin 3Therapeutics 2Sugars 2Radiotherapy 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2Diphenhydramine 2rolapitant 1netupitant 1isatuximab 1ginger extract 1dolasetron 1casopitant 1auricularum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nausea × Neoadjuvant Therapy × Clear all
NCT01031953 2017-05-09

Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy

OHSU Knight Cancer Institute

Phase 1/2 Terminated
34 enrolled 12 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡